Deutsche Bank AG Increases Stock Holdings in The Clorox Company (NYSE:CLX)

Deutsche Bank AG lifted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 654,198 shares of the company's stock after acquiring an additional 80,189 shares during the period. Deutsche Bank AG owned approximately 0.53% of Clorox worth $106,248,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. California Public Employees Retirement System boosted its position in Clorox by 1.3% in the fourth quarter. California Public Employees Retirement System now owns 565,810 shares of the company's stock valued at $91,893,000 after buying an additional 6,987 shares during the last quarter. Fifth Third Wealth Advisors LLC acquired a new position in Clorox in the fourth quarter valued at approximately $204,000. Apollon Wealth Management LLC lifted its holdings in Clorox by 119.6% in the fourth quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company's stock valued at $546,000 after acquiring an additional 1,832 shares during the period. Miracle Mile Advisors LLC acquired a new position in Clorox in the fourth quarter valued at approximately $1,566,000. Finally, Wellington Management Group LLP lifted its holdings in Clorox by 18.8% in the fourth quarter. Wellington Management Group LLP now owns 4,074 shares of the company's stock valued at $662,000 after acquiring an additional 646 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Insider Buying and Selling

In other news, Director Pierre R. Breber purchased 4,000 shares of the company's stock in a transaction that occurred on Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director now directly owns 4,000 shares of the company's stock, valued at $546,280. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.57% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research analysts have issued reports on CLX shares. UBS Group decreased their price target on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Barclays reduced their target price on Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research note on Wednesday, May 7th. Evercore ISI set a $140.00 target price on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Citigroup reduced their target price on Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research note on Monday, April 14th. Finally, Wells Fargo & Company reduced their target price on Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $151.23.

Clorox Stock Down 1.2%

CLX stock traded down $1.60 during mid-day trading on Tuesday, reaching $136.46. The company had a trading volume of 1,338,173 shares, compared to its average volume of 1,311,181. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market capitalization of $16.82 billion, a price-to-earnings ratio of 37.28, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The firm has a fifty day simple moving average of $141.91 and a 200 day simple moving average of $153.78. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period last year, the business posted $1.71 EPS. Clorox's revenue was down 8.0% on a year-over-year basis. Analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were paid a dividend of $1.22 per share. The ex-dividend date was Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.58%. Clorox's dividend payout ratio is presently 87.61%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.